WallStreetZenWallStreetZen

NASDAQ: INMB
Inmune Bio Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Inmune Bio revenue was $50.00k for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INMB annual revenue was $14.0k, with -91% growth year-over-year.

INMB past revenue growth

How has INMB's revenue growth performed historically?

Company
19.05%
Industry
150.53%
Market
20.47%
INMB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INMB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INMB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INMB revenue history

Current Revenue
$50.0k
Current Earnings
-$49.9M
Current Profit Margin
-99,774%

Be the first to know when INMB announces revenue.

INMB Revenue History By Year

INMB Yearly RevenueINMB RevenueINMB ChangeINMB Revenue Growth
2024-12-31$14.00k-$141.00k-90.97%
2023-12-31$155.00k-$219.00k-58.56%
2022-12-31$374.00k$193.00k+106.63%
2021-12-31$181.00k$170.00k+1,545.45%
2020-12-31$11.00kN/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A

1 of 1

Inmune Bio Revenue FAQ

What was INMB's revenue last quarter?

On Invalid Date, Inmune Bio (NASDAQ: INMB) reported Q3 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Inmune Bio's revenue was $0.00.

What was Inmune Bio's revenue in 2024?

Inmune Bio's annual revenue for the twelve months ending Dec 31, 2024 was $14.00 thousand, a 90.97% decrease year over year.

How much does Inmune Bio make in a day?

Based on Inmune Bio annual revenue for the past five years, INMB makes an average of $402.74 per day.

What was Inmune Bio's annual revenue growth in the past year?

As of Q4 2025, Inmune Bio's revenue has grown 19.05% year over year. This is 131.48 percentage points lower than the US Biotechnology industry revenue growth rate of 150.53%. Inmune Bio's revenue in the past year totaled $50.00 thousand.

How much does Inmune Bio make in a year?

Inmune Bio's revenue by year for the past five years is:
  • Inmune Bio's revenue for the twelve months ending Dec 31, 2024 was $14.00 thousand, a 90.97% decrease year over year.
  • Inmune Bio's annual revenue for Dec 31, 2023 was $155.00 thousand, a 58.56% decrease from 2022.
  • Inmune Bio's annual revenue for 2022 was $374.00 thousand, a 106.63% increase from 2021.
  • Inmune Bio's annual revenue for 2021 was $181.00 thousand, a 1,545.45% increase from 2020.
  • Inmune Bio's annual revenue for 2020 was $11.00 thousand, a Infinity% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.